首页> 外文期刊>BJOG: an international journal of obstetrics and gynaecology >The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 microg in first trimester pregnancies.
【24h】

The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 microg in first trimester pregnancies.

机译:口服米索前列醇用于流产前子宫颈促发的方法:妊娠中期妊娠400毫克对200毫克的随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To compare the impact of 200 and 400 microg oral misoprostol on pre-operative cervical priming in both primi- and multigravidae prior to first trimester termination of pregnancy. Pre-operative cervical dilatation and bleeding were assessed. DESIGN: Randomised controlled trial. SETTING: Norwegian university teaching hospital. SAMPLE: Five hundred and fifty-one women undergoing surgical termination of pregnancy between 7 and 12 weeks of gestation. METHODS: Patients were randomised to either 200 or 400 microg of oral misoprostol 10-16 hours before vacuum aspiration. The degree of cervical dilatation prior to abortion by vacuum aspiration was measured. Pre-operative bleeding and pain were recorded and vaginal bleeding was measured. MAIN OUTCOME MEASURES: Degree of pre-operative cervical dilatation and pre-operative bleeding. RESULTS: The mean cervical dilatation was 5.8 mm (SD 1.7) for the women who received 400 microg misoprostol and 5.4 mm (SD 1.4) for those who received 200 microg (P= 0.004).The pre-operative dilatation was larger in multigravidae than in primigravidae in both dosage groups. The odds ratio (OR) of pre-operative bleeding was 3.3 (95% confidence interval [CI] 2.1-5.0) in the 400 microg dosage group, as compared with the group receiving 200 microg misoprostol. The occurrence of bleeding was dose-dependent. Frequency of bleeding was similar in multigravidae compared with primigravidae in the 400 microg dosage group, whereas the occurrence of bleeding was less in primigravidae than multigravidae in the 200 microg dosage group. Only 89 out of 551 patients bled one or more grams. The volumes measured were not statistically significantly different. Complications were minor, and were distributed equally between the two dosage groups. CONCLUSIONS: The 200 microg oral misoprostol compared with the 400 microg oral misoprostol given 10-16 hours before first trimester surgical abortions results in less pre-operative vaginal bleeding and in a statistically, although not clinically significant reduction in cervical dilatation.
机译:目的:比较200和400微克口服米索前列醇对妊娠早孕终止的初产和复胎术前宫颈启动的影响。评估术前宫颈扩张和出血情况。设计:随机对照试验。地点:挪威大学教学医院。样本:551名在妊娠7至12周之间接受手术终止妊娠的妇女。方法:在真空抽吸前10-16小时,将患者随机分为200或400微克口服米索前列醇。测量通过真空抽吸流产之前宫颈的扩张程度。记录术前出血和疼痛,并测量阴道出血。主要观察指标:术前宫颈扩张程度和术前出血程度。结果:接受米索前列醇400微克的女性平均宫颈扩张为5.8 mm(SD 1.7),接受200 microg的女性平均宫颈扩张为5.4 mm(SD 1.4)(P = 0.004)。在两个剂量组中,初生科动物中都存在。与接受200微克米索前列醇的组相比,在400微克剂量组中,术前出血的比值比(OR)为3.3(95%置信区间[CI] 2.1-5.0)。出血的发生是剂量依赖性的。在400微克剂量组中,多胎科动物的出血频率与初生科动物相似,而在200微克剂量组中,初生科动物的出血发生率比多胎科动物少。 551名患者中只有89名出血一克或更多克。所测量的体积在统计学上没有显着差异。并发症很少,并且在两个剂量组之间平均分配。结论:200毫克口服米索前列醇与400毫克口服米索前列醇相比,在妊娠早期流产前10-16小时给予的结果是较少的术前阴道出血,尽管在临床上宫颈扩张没有显着减少,但具有统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号